Wcn23-1085 a phase 3, randomized, double-blind, placebo-controlled study of atrasentan in patients with iga nephropaty- the align study
Kidney International Reports(2023)
关键词
atrasentan,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要